c semaglutide vs Tirzepatide for Weight Loss A Pharmacological and Clinical Overview

Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of antihyperglycemic drugs that have demonstrated potent HbA1c reduction, low risk of hypoglycemia, with associated weight reduction, and proven cardiovascular and renal benefits.24 In this review we describe this type of drugs, their cardiovascular and renal benefits, as well as their clinical potential in patients with DKD, especially with the new oral semaglutide formulation, now available on the market

Prior gallbladder removal (cholecystectomy) does not contraindicate semaglutide use

Excellent way to accelerate weight loss when your current GLP seems to slow down after titration doses

Will Menstrual Changes Persist After Stopping GLP-1